What Is the Best ETF to Buy This Year?
The stock market has gotten off to an extremely rough…
Sell
36
JANX Quote, Financials, Valuation and Earnings
Last price:
$25.95
Seasonality move
:
-4.46%
Day range:
$25.77 - $27.41
52-week range:
$25.77 - $71.71
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
111.17x
P/B ratio:
1.56x
Volume:
834.4K
Avg. volume:
867.6K
1-year change:
-25.73%
Market cap:
$1.6B
Revenue:
$10.6M
EPS (TTM):
-$1.28
Earnings Data
Next earnings date for JANX
May 08
2025
Most recent earnings per share
-$0.36
Beat by $0.09
(Dec 31/2024)
Consensus Estimate
-$0.45
(Dec 31/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
JANX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $600K | -- | -- | -$0.45 | -- |
| 05/08/2025 | Q1 | $590.9K | -- | -- | -$0.39 | -- |
| 12/31/2024 | Q4 | $1.3M | -- | -$0.36 | -$0.45 | $0.09 |
| 11/06/2024 | Q3 | $1.6M | $439K | -$0.51 | -$0.36 | -$0.15 |
| 08/07/2024 | Q2 | $863.1K | $8.9M | -$0.11 | -$0.29 | $0.18 |
| 05/08/2024 | Q1 | $1M | $1.3M | -$0.30 | -$0.33 | $0.03 |
| 03/08/2024 | Q4 | $739.3K | $2.5M | -$0.24 | -$0.39 | $0.15 |
| 11/07/2023 | Q3 | -- | -- | -$0.25 | -$0.43 | $0.18 |
| 08/08/2023 | Q2 | -- | -- | -$0.42 | -$0.51 | $0.09 |
| 05/09/2023 | Q1 | -- | -- | -$0.42 | -$0.47 | $0.05 |
| 03/10/2023 | Q4 | -- | -- | -$0.39 | -$0.50 | $0.11 |
| 11/10/2022 | Q3 | -- | -- | -$0.40 | -$0.53 | $0.13 |
| 08/09/2022 | Q2 | -- | -- | -$0.41 | -$0.39 | -$0.02 |
| 05/10/2022 | Q1 | -- | -- | -$0.32 | -- | -- |
| 03/18/2022 | Q4 | -- | -- | -$0.33 | -- | -- |
| 11/09/2021 | Q3 | -- | -- | -$0.26 | -- | -- |
| 08/10/2021 | Q2 | -- | -- | -$0.62 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.06 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.13 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.10 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.20 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.11 | -- | -- |
Janux Therapeutics Earnings Questions
-
How Much did Janux Therapeutics Generate in Revenue Last Quarter?
Janux Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Janux Therapeutics Beat Earnings Last Quarter?
Janux Therapeutics announced earnings per share of -$0.36 which represents a beat of analyst forecast a -$0.45 per share.
-
Is Janux Therapeutics Profitable?
Janux Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Janux Therapeutics EPS Next Year?
Janux Therapeutics's earnings are forecast to decrease from -$1.28 per share to -$1.30 per share next year representing a decrease of -59.72%.
-
When is Janux Therapeutics's Earnings Date?
Janux Therapeutics's next earnings date is May 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Bad News Priced Into Nike Stock Now?
Despite its dominance in the athletic shoe and apparel industry,…
Is LUV Stock a Buy, Sell or Hold?
Southwest Airlines (NYSE:LUV) is one of America’s major air transportation…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 33x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
37
Is NVDA Stock a Buy?
Market Cap: $2.5T
P/E Ratio: 35x
Alerts
Sell
29
RH alert for Apr 4
RH [RH] is down 13.15% over the past day.
Sell
24
DPST alert for Apr 4
Direxion Daily Regional Banks Bull 3X Shares [DPST] is down 19.44% over the past day.
Buy
81
SOXS alert for Apr 4
Direxion Daily Semiconductor Bear 3X Shares [SOXS] is up 20.18% over the past day.
